Stocks · Healthcare · Medical - Devices
Hyperfine, Inc. HYPR
$0.89 +2.54% Close, Oct 2, 2026 · NASDAQ · Market cap $75.3M
Strong growthWeak trend
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -203.3% from -391.1% a year earlier.
- The diluted share count rose 27.8% in a year.
- Revenue over the last four quarters was $16.5M, up 53.2% from a year earlier, accelerating from 30.7% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 16%
- Revenue growth, 3-year CAGRTop 25%
- Revenue growth accelerationTop 8%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 19%
- Gross marginBottom 35%
- Operating marginBottom 24%
- Accruals (lower is better)Top 28%
- Interest coverBottom 16%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 17%
- Free-cash-flow yieldBottom 13%
- EBITDA / enterprise valueBottom 7%
- Sales / enterprise valueTop 35%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 9%
- 6-month returnBottom 23%
- 1-year return vs S&P 500Bottom 17%
- Distance from 52-week highBottom 17%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 38%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 45%
- Upside to consensus price targetTop 32%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 29%
- Maximum drawdown, 3 yearsBottom 45%
- Beta vs S&P 500 (lower is better)Top 46%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 30.7% | 53.2% | ↑ |
| Gross margin | 45.8% | 51.4% | ↑ |
| Operating margin | -391.1% | -203.3% | ↑ |
| FCF margin | -325.9% | -166.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 53.2% | 30.7% | ↑ | Top 16% |
| Gross margin | 51.4% | 45.8% | ↑ | Bottom 35% |
| Operating margin | -203.3% | -391.1% | ↑ | Bottom 24% |
| Net margin | -210.8% | -364.5% | ↑ | — |
| Free-cash-flow margin | -166.5% | -325.9% | ↑ | — |
| Return on invested capital | -62.8% | — | Bottom 19% | |
| Revenue growth, 3-year CAGR | 25.8% | — | Top 25% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -12.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 17.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -69.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -54.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -43.94%
- Shareholder yield
- -43.94%
- Share count change, 1 year
- +27.8%
- Share count change, 3-year CAGR
- +11.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -2.5%
- Average 2-day reaction, last 8
- +4.6%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $2.00
- Target vs current price
- +123.8%
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 80%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +0.0% | +0.2% | -8.1% | -17.8% | — |
| May 12, 2026 | +0.0% | -1.1% | -17.1% | -18.9% | -43.9% |
| Mar 18, 2026 | +0.0% | -2.3% | -11.5% | -0.8% | +9.2% |
| Nov 13, 2025 | -10.0% | -4.5% | -2.7% | -9.1% | -0.9% |
| Aug 13, 2025 | +0.0% | +5.8% | +5.8% | +10.0% | -5.8% |
| May 13, 2025 | +0.0% | -4.1% | -14.3% | +9.5% | +57.5% |
| Mar 17, 2025 | +12.5% | +39.3% | -10.8% | -20.2% | -13.0% |
| Nov 12, 2024 | +0.0% | +3.2% | -6.3% | +9.8% | +85.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.09 | -$0.09 | +0.0% | $3.9M |
| May 12, 2026 | -$0.09 | -$0.09 | +0.0% | $3.9M |
| Mar 18, 2026 | -$0.08 | -$0.08 | +0.0% | $5.3M |
| Nov 13, 2025 | -$0.11 | -$0.10 | -10.0% | $3.4M |
| Aug 13, 2025 | -$0.12 | -$0.12 | +0.0% | $2.7M |
| May 13, 2025 | -$0.12 | -$0.12 | +0.0% | $2.1M |
| Mar 17, 2025 | -$0.14 | -$0.16 | +12.5% | $2.3M |
| Nov 12, 2024 | -$0.14 | -$0.14 | +0.0% | $3.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2.73× | — | — | Top 35% |
| Free-cash-flow yield | -36.57% | — | — | Bottom 13% |
| Earnings yield | -42.83% | — | — | Bottom 17% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 2
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -14.3%
- 200-day average slope (20 days)
- -1.9%
- Distance from 50-day average
- +3.2%
- Distance from 200-day average
- -22.5%
- RSI (14)
- 61.6
- Relative volume
- 3.05×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.6%
- Volatility vs own 5-year history
- 6th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.04
- Correlation with S&P 500
- 0.18
- Current drawdown from 1-year high
- -59.4%
- Maximum drawdown, 3 years
- -73.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 22, 2021 | May 23, 2025 | -95.0% | 857 days | Not yet recovered |
| Feb 16, 2021 | Jun 23, 2021 | -10.5% | 89 days | 127 days (Dec 22, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $75.3M
- EPS, diluted (TTM)
- -$0.38
- Revenue (TTM)
- $16.5M
- 52-week range
- $0.75 – $2.22
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.5M | $6.8M | $11.0M | $12.9M | $13.6M |
| Gross profit | -$1.2M | $907,000 | $4.8M | $5.9M | $6.8M |
| Operating income | -$64.9M | -$73.9M | -$48.1M | -$43.2M | -$37.1M |
| Net income | -$64.8M | -$73.2M | -$44.2M | -$40.7M | -$35.6M |
| EPS (diluted) | -$0.92 | -$1.04 | -$0.62 | -$0.56 | -$0.43 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6M | $2.3M | $2.1M | $2.7M | $3.4M | $5.3M | $3.9M | $3.9M |
| Net income | -$10.3M | -$10.4M | -$9.4M | -$9.2M | -$11.0M | -$5.9M | -$8.6M | -$9.3M |
| EPS (diluted) | -$0.14 | -$0.14 | -$0.12 | -$0.12 | -$0.14 | -$0.06 | -$0.09 | -$0.09 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$47.2M | -$72.3M | -$41.8M | -$38.8M | -$27.9M |
| Capital expenditure | -$2.7M | -$585,000 | -$804,000 | -$383,000 | -$1.2M |
| Free cash flow | -$49.9M | -$72.9M | -$42.6M | -$39.1M | -$29.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $1.5M | $7,000 | $174,000 | $848,000 | $27.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $43.5M
- Total assets
- $63.0M
- Total liabilities
- $26.2M
- Total debt
- $13.4M
- Net debt
- -$30.0M
- Shareholders’ equity
- $36.8M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 4,236,754
- Days to cover
- 11.25
- Change vs previous report
- +16.1%
FINRA short interest, settlement date Sep 15, 2026.